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Aquaporin Deletion in Mice Reduces Intraocular Pressure
and Aqueous Fluid Production
 
Duo Zhang, L. Vetrivel, 
 
and
 
 A.S. Verkman
 
Departments of Medicine and Physiology, Cardiovascular Research Institute, University of California at San Francisco,
San Francisco, CA 94143
 
abstract
 
Aquaporin (AQP) water channels are expressed in the eye at sites of aqueous fluid production and
outflow: AQP1 and AQP4 in nonpigmented ciliary epithelium, and AQP1 in trabecular meshwork endothelium.
Novel methods were developed to compare aqueous fluid dynamics in wild-type mice versus mice lacking AQP1
and/or AQP4. Aqueous fluid production was measured by in vivo confocal microscopy after transcorneal ionto-
phoretic introduction of fluorescein. Intraocular pressure (IOP), outflow, and anterior chamber compliance were
determined from pressure measurements in response to fluid infusions using micropipettes. Aqueous fluid vol-
 
ume and [Cl
 

 
] were assayed in samples withdrawn by micropipettes. In wild-type mice (CD1 genetic background,
 
age 4–6 wk), IOP was 16.0 
 

 
 0.4 mmHg (SE), aqueous fluid volume 7.2 
 

 
 0.3 
 

 
l, fluid production 3.6 
 

 
 0.2 
 

 
l/h,
fluid outflow 0.36 
 

 
 0.06 
 

 
l/h/mmHg, and compliance 0.036 
 

 
 0.006 
 

 
l/mmHg. IOP was significantly decreased
 
by up to 1.8 mmHg (
 
P
 
 
 
 
 
0.002) and fluid production by up to 0.9 
 

 
l/h in age/litter-matched mice lacking AQP1
and/or AQP4 (outbred CD1 and inbred C57/bl6 genetic backgrounds). However, AQP deletion did not signifi-
cantly affect outflow, [Cl
 

 
], volume, or compliance. These results provide evidence for the involvement of AQPs
in intraocular pressure regulation by facilitating aqueous fluid secretion across the ciliary epithelium. AQP inhibi-
tion may thus provide a novel approach for the treatment of elevated IOP.
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I N T R O D U C T I O N
 
The hydrostatic pressure of the aqueous fluid compart-
ment of the eye, defined as intraocular pressure
(IOP),* is an important index of eye physiology. Glau-
coma is usually associated with elevated IOP. The prin-
cipal determinants of IOP are the rate of aqueous fluid
production by the ciliary epithelium and the rate of
fluid drainage in the canal of Schlemm. Aqueous fluid
production involves passive, near-isosmolar water trans-
port driven by active salt transport across the ciliary epi-
thelium. Several ion and solute transporters have been
identified on pigmented and nonpigmented layers of
the ciliary epithelium, which probably facilitate active
solute transport. Aqueous fluid drainage is believed to
involve pressure-driven bulk fluid flow in the canal of
Schlemm as well as fluid movement through the sclera
by seepage across the ciliary muscle and supraciliary
space (Johnstone and Grant, 1973; Brandt and O’Don-
nell, 1999).
The transport of water across some cell plasma mem-
branes is facilitated by aquaporin (AQP) water chan-
nels, which are small transmembrane proteins that
function as passive conduits for osmotically or hydro-
statically-driven water transport. AQP1 and AQP4 are
expressed in nonpigmented ciliary epithelial cells in
human and rat eye (Nielsen et al., 1993; Hasegawa et
al., 1994; Stamer et al., 1994; Frigeri et al., 1995; Ha-
mann et al., 1998) and have been proposed to play a
role in aqueous fluid production and thus IOP regula-
tion. Studies in transgenic mice lacking AQP1 or AQP4
have indicated that they play an important role in the
urinary concentrating mechanism (Ma et al., 1997;
1998), cerebral fluid balance (Manley et al., 2000), cor-
neal fluid balance (Thiagarajah and Verkman, 2002),
hearing (Li and Verkman, 2001), and osmotically
driven water transport in lung (Bai et al., 1999; Song et
al., 2000a). Impaired near-isosmolar fluid absorption in
kidney proximal tubules of AQP1 null mice (Schner-
mann et al., 1998) and impaired fluid secretion in sali-
vary (Ma et al., 1999) and submucosal glands (Song
and Verkman, 2001) of AQP5 null mice support the
paradigm that AQP water channels are required for
rapid, near-isosmolar fluid transport, as is thought to
occur in aqueous fluid production by the ciliary epithe-
lium. AQP1 is also expressed strongly in endothelial
cells in the trabecular meshwork and canal of Schlemm
(Stamer et al., 1994; Patil et al., 1997). Deletion of
AQP1 in endothelial cells of the renal vasa recta im-
pairs osmotically driven water transport and urinary
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concentrating ability (Pallone et al., 2000). However, al-
though deletion of AQP1 in microvascular endothelia
in lung (Bai et al., 1999) and pleura (Song et al.,
2000b) also decreases osmotic water permeability, nei-
ther isosmolar fluid absorption nor other physiologi-
cally important processes appear to be impaired. If out-
flow occurs exclusively by a bulk flow mechanism, it is
thus unlikely that AQP1 in endothelia in the trabecular
meshwork is involved in aqueous fluid outflow. How-
ever, a recent study suggested that AQP1 may be im-
portant in trabecular endothelial volume regulation
(Stamer et al., 2001), which may influence bulk fluid
flow indirectly by changing the geometry of the aque-
ous fluid exit pathway.
The purpose of this study was to test the hypothesis
that AQPs play a role in aqueous fluid dynamics and
thus intraocular pressure regulation. To make quantita-
tive comparisons in wild-type versus AQP null mice,
novel methods were developed to measure the key
properties of the aqueous fluid compartment includ-
ing: IOP, volume, ionic composition, compliance, fluid
production, and fluid outflow. Recent studies have re-
ported IOP measurements in mice (John et al., 1997;
Avila et al., 2001; Cohen and Bohr, 2001), but the other
properties have not been measured. The challenges in
these measurements include the small size (
 

 
7 
 

 
l
aqueous fluid volume, see 
 
results
 
) and complex ge-
ometry of the anterior chamber with little space be-
tween the corneal endothelium and lens surface, as
well as the mechanical toughness of the cornea. Several
strategies were evaluated and optimized in establishing
the methods reported here. The new methods for mea-
surement of the static and dynamic properties of aque-
ous fluid in the mouse eye should have wide applica-
tions in functional genomics using mouse models. The
measurements in AQP1 and AQP4 null mice provide
the first functional data concerning the role of an AQP
in eye physiology, and provide evidence that AQPs are
involved in IOP regulation by facilitating aqueous fluid
production.
 
M A T E R I A L S  A N D  M E T H O D S
 
Transgenic Mice
 
Transgenic knockout mice deficient in AQP1 and AQP4 were
generated by targeted gene disruption in an outbred CD1 ge-
netic background as originally described (Ma et al., 1997, 1998).
The AQP1 and AQP4 null genotypes were transferred to a C57/
bl6 inbred background by more than nine backcrosses. AQP1/
AQP4 double knockout mice were generated by serial breedings
of the single knockout mice (Song et al., 2000b). Measurements
were done in matched wild-type and knockout mice of age 4–6
wk (weight 27–33 g). Mice were housed in the University of Cali-
fornia at San Francisco animal facility, fed standard mouse chow
(4% fat), and maintained on a 12 h light/12 h dark cycle. The in-
vestigators were blinded to genotype information until comple-
tion of the analysis. Protocols were approved by the University of
California at San Francisco Committee on Animal Research and
 
are in compliance with the ARVO statement for the use of ani-
mals in ophthalmic and vision research.
 
Mouse Preparation
 
Mice were generally anesthetized using ketamine (250 mg/kg in-
traperitoneal) alone (Burke and Potter, 1986). In some experi-
ments, anesthesia was done using ketamine (100 mg/kg) and xy-
lazine (9 mg/kg), or pentobarbital (50 mg/kg). The cornea was
anesthetized using topical proparacaine (0.5%). Mice were im-
mobilized using a stereotaxic device (Kopf) and body tempera-
ture was maintained at 37 
 

 
 1
 

 
C using a heating device and rec-
tal temperature probe. The eye was observed using a neurosurgi-
cal stereomicroscope (ZEISS) with motor-driven focus and zoom.
Corneal drying was prevented using topical saline (325 mOsm to
match mouse serum osmolality) that was perfused onto the cor-
neal surface at a rate of 10 
 

 
l/min using nylon suture as a wick to
prevent drop formation. The osmolality of the corneal bathing
fluid remained 
 

 
325 mOsm, indicating that evaporation and hy-
perosmolality did not occur.
 
Micropipettes
 
IOP was measured using a fluid-filled micropipette introduced
into the aqueous compartment through the cornea. A very sharp
micropipette that sliced through the cornea with minimal cor-
neal depression and trauma was found to be essential for these
measurements. Initially, micropipettes were fashioned from
borosilicate glass using a vertical pipette puller (model 700C;
Kopf) and horizontal microforge (model MF900; Narishige). Tip
outer diameters of 25–75 
 

 
m were tested. Micropipettes tips
were beveled at angles of 45–60
 

 
 (from pipette axis) using a rotat-
ing wheel microgrinder (model BV10; Sutter Instruments Co.),
and the tip was sharpened using the microforge. Micropipettes
of outer diameter 45 
 

 
m, bevel angle 50
 

 
, and short sharp tip
were found to be best. However, substantially better micropi-
pettes were prepared by simply breaking the glass pipettes, which
yielded a longer bevel than that which could be fashioned with
the microgrinder. Pipettes prepared in this manner were evalu-
ated by microscopy; approximately one out of four micropipettes
were judged visually to be suitable for IOP measurements. These
micropipettes readily sliced through the cornea and the same mi-
cropipette was generally used for IOP and outflow measurements
on 
 

 
20 mice with reproducible results.
 
IOP
 
Micropipettes were introduced into the mouse cornea using a
4-axis micromanipulator (Narishige) at an angle of 45
 

 
 from the
vertical at a location of 
 

 
0.2 mm from the center of the cornea.
Care was taken to avoid contact with the lens surface. Micropi-
pettes were connected using short noncompliant tubing to a
pressure transducer (MX860; Medex, Inc.) interfaced to a re-
cording system (model MP100; Biopac). The circuit also permit-
ted fluid introduction using a syringe pump (Harvard Appara-
tus) driving a gas-tight glass Hamilton syringe. The quality of the
tubing and connections was found to be critical for accurate and
stable IOP measurements, as well as elimination of small air bub-
bles. At the completion of each experiment the micropipette tip
was withdrawn from the cornea to verify a reading of 0 mmHg. In
validation studies, IOP was set at a series of specified levels (3.7–22
mmHg) by introducing a second micropipette into the anterior
chamber that was connected to a fluid manometer (see Fig. 1 A).
 
Aqueous Fluid Outflow Dynamics
 
Two independent methods were used to measure aqueous
fluid outflow: a continuous infusion method and a pulsed in-
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fusion method; the latter method also provided information
about the compliance of the aqueous fluid compartment. In
the continuous infusion method, as reported for measure-
ments in rat eye (Mermoud et al., 1996), IOP was monitored
during continuous perfusion of fluid into the aqueous com-
partment. The rate of fluid infusion was determined empiri-
cally (see Fig. 2 A) to maintain constant IOP at a series of pre-
determined levels. In the pulsed infusion method, 0.1 
 

 
l infu-
sions (rate, 20 ml/min) of fluid were made every minute
during continuous IOP recording (see Fig. 3 A). From these
data, volume vs. pressure (V vs. IOP) and outflow vs. pressure
(dV/dt vs. IOP) curves were constructed for each eye studied
(and later averaged for mice of the same genotype and ge-
netic background) as follows: for each 0.1 
 

 
l fluid infusion,
the initial and final IOPs were tabulated along with the slope
[d(IOP)/dt]. Aqueous fluid volume was computed at each
IOP from the measured volume at physiological IOP (see be-
low) and the summed incremental volumes resulting from the
fluid additions (after correction for outflow). The resultant V
vs. IOP relation defines the compliance of the aqueous fluid
compartment. Aqueous fluid outflow was computed from
d(IOP)/dt and compliance: dV/dt 
 
 
 
dV/d(IOP) · d(IOP)/
dt. Since measured outflow at physiological IOP (IOP
 
o
 
) is
zero as determined by the continuous and pulsed infusion
methods, the measured outflow is less than total outflow at
each IOP by a quantity equal to the inflow at physiological
IOP. We therefore report outflow as dV/dt vs. 
 
	
 
(IOP), where
 
	
 
(IOP) 
 

 
 IOP 
 

 
 IOP
 
o
 
.
 
Aqueous Fluid Production
 
Aqueous fluid production was measured from the kinetics of
disappearance of fluorescein from anterior chamber fluid, a
strategy used previously in human (Jones and Maurice, 1966;
Pederson et al., 1978) and monkey (Bill, 1971) eyes. For the
mouse eye, fluorescein was introduced into the anterior cham-
ber fluid by iontophoresis (see Fig. 4 A, top) and detected by
z-scanning confocal microscopy. The iontophoresis power supply
consisted of an 84-V direct current supply, selectable resistors to
set current, and a capacitor to attenuate current transients dur-
ing switching. A cotton swab wetted with isosmolar sucrose (pH
7.3) containing 0.5 
 

 
M Na fluorescein (Sigma-Aldrich) made
gentle contact with the central part of the cornea. A 0.2 mA cur-
rent was passed across the cornea for 2 min. The cotton swab
was connected to the negative electrode using an alligator clip
and the positive electrode was connected to a needle inserted
subcutaneously at the back of the neck. The cornea was then
rinsed with saline and the procedure repeated using a cotton
swap wetted with isosmolar sucrose (not containing fluores-
cein). Fluorescein concentration in the aqueous fluid was mea-
sured by z-axis scanning confocal microscopy using an appara-
tus described previously for measurement of airway surface liq-
uid depth (Jayaraman et al., 2001). The apparatus consisted of
a Leitz upright microscope (Diaplan) containing a Nipkow
wheel coaxial-confocal module (model K2S-BIO; Technical In-
struments Co.) (see Fig. 4 A, bottom). Fluorescence was de-
tected using a standard fluorescein filter set, photomultiplier
detector, and 50
 


 
 long working distance objective lens (Nikon,
numerical aperture 0.55, working distance 8.7 mm). The z-scan
was accomplished using a stepper motor (Compumotor) driv-
ing the microscope fine focus at a scan rate of 500 
 

 
m/s. In cal-
ibration/validation experiments, confocal fluorescence z-scans
were compared with aqueous fluid fluorescein concentrations
measured in fluid samples drawn into microcapillaries. A series
of different aqueous fluid fluorescein concentrations were gen-
erated (in separate eyes) by varying iontophoresis times from
0–3 min.
 
Aqueous Fluid Volume and [Cl
 

 
]
 
Aqueous fluid samples were collected in empty microcapillary
tubes introduced into the anterior chamber as described above.
Collection of the final microliter of fluid required gentle com-
pression of the anterior globe until the posterior surface of the
cornea made complete contact with the lens. Validation measure-
ments using wide-field fluorescence microscopy after introduc-
tion of fluorescein into the aqueous fluid indicated that 
 

 
95% of
aqueous fluid was withdrawn. Total fluid volume was measured
by the length of the fluid column, and [Cl
 

 
] was measured by
two-color fluorescence using the indicators lucigenin and sulfo-
rhodamine 101 as described for analysis of tear fluid collected
from mouse eyes (Moore et al., 2000).
 
Immunocytochemistry and Morphology
 
Mice were perfused via the aorta with 4% heparin in PBS, then
with freshly prepared 4% paraformaldehyde in PBS for immuno-
cytochemistry and 2% paraformaldehyde 
 

 
 2.5% glutaraldehyde
in 0.1 M sodium cacodylate buffer for light microscopy. Eyes were
enucleated after immersion in the fixative solution for 2 h at
room temperature after making a small cut in the cornea. Immu-
nocytochemistry was done on frozen sections and Toluidine blue
staining on plastic sections as described previously (Li et al.,
2002).
 
R E S U L T S
 
Initial experiments confirmed the expression of AQP1
and AQP4 in nonpigmented ciliary epithelium of wild-
type CD1 and C57/bl6 mice, and AQP1 in canal of
Schlemm endothelia, in agreement with reports on hu-
man and rat eye. As expected for these complete
knockout mice, AQP1 and AQP4 immunostaining was
absent in eyes of respective null mice. Also, there were
no differences in anterior chamber morphology, as as-
sessed in stained thin plastic sections.
IOP in anesthetized mice was measured by insertion
of a micropipette through the cornea into the anterior
chamber (Fig. 1 A). Accurate IOP measurement re-
quired a very sharp pipette tip to avoid corneal trauma
or disturbance of the lens, as well as a tight, noncom-
plaint fluid circuit. Fig. 1 B shows a validation study
(one experiment typical of three) in which IOP was set
by introduction of a second micropipette connected to
a saline-filled manometer. After brief transient re-
sponses due to changes in manometer fluid heights,
measured IOP agreed with the pressures set by the ma-
nometer. Subsequent IOP measurements were done us-
ing a single micropipette. As shown by the representa-
tive data in Fig. 1 C (top curve), IOP was generally sta-
ble for 
 

 
30 min. IOP was decreased by mannitol or
acetazolamide administration, and increased by intra-
peritoneal water administration, as expected (Fig. 1 C).
Control studies showed good concordance in IOP mea-
sured in left versus right eyes (
 

 
1.3 mmHg difference
in 
 

 
75% of mice, range 1.4–2.6 in remaining 25%).
Analysis of different anesthetic regimens show on aver-
age a small decrease in IOP (1.6 
 

 
 0.5 mmHg) using
ketamine/xylazine vs. ketamine alone, and a greater
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decrease (2.6 
 

 
 0.8 mmHg) using pentobarbital. Fig.
1 D summarizes IOP measurements on a series of
wild-type mice, AQP1 null mice, AQP4 null mice, and
AQP1/AQP4 double knockout mice, showing signifi-
cantly reduced IOP in each of the AQP-deficient mice.
Aqueous fluid outflow was measured initially by
a continuous infusion method. A micropipette con-
nected to a pressure transducer and infusion pump was
introduced into the anterior chamber. Fluid was in-
fused continuously at rates adjusted empirically to
maintain predetermined IOP values (Fig. 2 A). The in-
set shows a magnified view of the rate adjustments
made to give a constant IOP of 
 

 
25 mmHg. Fig. 2 B
shows a linear relationship between aqueous fluid out-
flow (
 

 
l/h) and 
 
	
 
(IOP) (
 

 
 IOP 
 

 
 IOP
 
o
 
), giving an
outflow rate (slope) of 0.35 
 

 
 0.03 
 

 
l/h/mmHg, sub-
stantially less than that of 2.6 
 

 
l/h/mmHg in rat eye
(Mermoud et al., 1996). Decreased outflow resistance
was not seen in these studies which generally were com-
pleted within 15 min after micropipette insertion. In
control studies, the kinetics of decreasing IOP was mea-
sured in four mice after elevating IOP to 30 mm Hg by
continuous fluid infusion (
 

 
4 
 

 
l/h) and then sud-
denly stopping perfusion. In two mice, the infusion was
done for 2 min and in the other two mice the infusion
 
was done for 10 min. The rate of IOP decrease after
stopping perfusion (
 

 
2 mmHg/min) was not af-
fected by the infusion time. Experiments were also
done to prove that aqueous fluid leakage did not oc-
cur at the micropipette insertion site, even at high in-
fusion rates and elevated IOP. After infusing fluid
containing fluorescein (10 
 

 
M) for 10 min at 4 
 

 
l/h
in eyes of two mice (without perfusing the corneal
surface), the fluorescein concentration in the fluid
on the corneal surface was 
 

 
10 nM, showing that no
leakage occurred.
For comparative measurements in AQP null mice, a
more sensitive and technically less tedious method in-
volving pulsed fluid infusions was developed. In the
pulsed infusion method, 0.1 
 

 
l fluid pulses were intro-
duced every minute during continuous IOP recording.
Each fluid addition produced a rapid increase in IOP,
which is related to anterior chamber compliance, fol-
lowed by a slower decline in IOP due to aqueous fluid
outflow (Fig. 3 A). The rate of decline in IOP following
fluid pulses was increased at higher IOPs, indicating
that outflow is pressure dependent. Experiments as in
Fig. 3 A were analyzed to determine the dependence of
aqueous fluid volume and outflow on IOP. Fig. 3 B
shows aqueous fluid volume as a function of IOP for
Figure 1. Intraocular pressure. (A) Schematic of measurement method showing the introduction of a fluid-filled micropipette into the
anterior chamber through the cornea. In calibration studies, a second micropipette connected to a fluid-filled manometer was inserted
(left, shown in gray). (B) Validation of IOP measurements. Measured IOP shown as a function of pressure set by manometer fluid height.
(C) Time course of IOP in wild-type mice. Where indicated mice were given mannitol (20%, 2.5 g/kg), acetazolamide (8 mg/kg), or water
(0.1 ml/g, intraperitoneal). (D) IOP measurements in wild-type mice, AQP1 and AQP4 null mice, and AQP1/AQP4 double knockout
mice showing data in individual eyes (filled circles) and mean  SE (open circles). *, P  0.05, **, P  0.002 (ANOVA).
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wild-type and AQP1 null mice. Aqueous fluid volume
was computed from the incremental changes in IOP as
described in 
 
materials and methods
 
, using an aver-
age measured volume of 7 
 

 
l at physiological IOP (see
below) for absolute volume determination. The slope
of the volume versus IOP relation defines the compli-
ance of the aqueous fluid compartment. Fig. 3 C shows
aqueous fluid outflow (dV/dt, 
 

 
l/h) as a function of
 
	
 
IOP. dV/dt was computed from the product of com-
pliance, dV/d(IOP), and the rate of decline in IOP,
d(IOP)/dt, following fluid pulses. Outflow rates given
by the continuous (0.35 
 

 
 0.03 
 

 
l/h/mmHg; Fig. 2 B)
and pulsed (0.36 
 

 
 0.06 
 

 
l/h/mmHg) infusion meth-
ods were in good agreement.
 
The approximately linear dependence of aqueous
fluid outflow on IOP is in agreement with data obtained
in rat (Mermoud et al., 1996) eye. Fig. 3 D (top) shows
that anterior chamber compliance (slope of volume vs.
IOP at IOP
 
o
 
) was not affected by AQP1 deletion in mice
of CD1 or C57/bl6 genetic backgrounds. Fig. 3 D (bot-
tom) shows that aqueous fluid outflow (slope of outflow
vs. 
 
	
 
(IOP)) was not impaired by AQP1 deletion.
Aqueous fluid production was measured from the ki-
netics of fluorescein disappearance from the aqueous
fluid after transcorneal iontophoresis. This approach is
based on the principle that inflow and outflow are
equal at IOP
 
o
 
, and that outflow occurs by bulk fluid
flow without sieving of the small fluorescein molecule.
Figure 2. Aqueous fluid outflow by the continuous infusion method. (A) Representative experiment showing IOP recording in response
to continuous fluid infusion. Fluid was infused continuously into the anterior chamber by a micropipette to obtain constant specified IOP.
Infusion was transiently increased to 10 l/h to increase IOP, followed by empirical changes by in 0.5-l/h steps to keep IOP constant.
(inset) Magnified view for setting IOP to 25 mmHg. (B) Aqueous fluid outflow versus 	(IOP) (IOP  IOPo) determined from experi-
ments as in A. Mean  SE, n  8 eyes.
Figure 3. Anterior chamber compliance and aqueous fluid outflow in wild-type and AQP1 null mice measured by the pulsed infusion
method. (A) Representative experiments showing continuous IOP recording in response to 0.1 l pulsed fluid infusions every minute.
The fluid infusions produced a rapid increase in IOP followed by a pressure-dependent decline due to outflow. (B) Aqueous fluid volume
versus IOP for CD1 mice of indicated genotype determined from experiments as in A, defining anterior chamber compliance (mean 
SE, n  8 eyes). See materials and methods for computation procedures. (C) 	(IOP)-dependent fluid outflow computed from rates of
IOP decrease following pulsed fluid infusions. (D) Averaged anterior chamber compliance (top) and aqueous fluid outflow (bottom) for
mice of indicated genotype and genetic background. Differences not significant.
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Fig. 4 A (top) shows the apparatus for iontophoresis,
which consists of a cotton swap moistened with an isos-
molar fluorescein-containing buffer in contact with the
cornea, and a power supply delivering specified current
through the cornea. Initial experiments were done to
optimize the current, iontophoresis time, and fluores-
cein concentration to introduce readily measurable
quantities of fluorescein into the aqueous fluid without
damage to the cornea and with minimal fluorescein re-
maining in the cornea. A short iontophoresis time (2
min) and a small current (0.2 mA) effectively loaded
the anterior chamber fluid with fluorescein, probably
because of the relatively thin mouse cornea (120 m
thickness) compared with corneas from humans and
larger animals (500 m). After rinsing the cornea,
electrical current was passed through the cornea for an
additional 2 min (without fluorescein) to drive most of
the remaining fluorescein out of the corneal stroma
into the aqueous fluid.
After testing various approaches to measure aqueous
fluid fluorescein concentration (wide-field microscopy
at low and high numerical aperture, micropipette sam-
pling), we used in vivo z-scanning fluorescence confo-
cal microscopy with a 50
 long working distance air
objective lens (Fig. 4 A, bottom). Confocal microscopy
permitted measurement of fluorescein concentration
in the aqueous fluid just beneath the corneal endothe-
lium with minimal geometric and scattering effects. To
validate the confocal measurement approach, z-scans
were obtained for a series of eyes in which different
amounts of fluorescein were introduced by varying ion-
tophoresis durations from 0 to 3 min. The peak heights
deduced by confocal microscopy (Fig. 4 B, right) were
compared with fluorescein concentrations measured in
microcapillary samples of aqueous fluid obtained just
after confocal microscopy. Fig. 4 B (left) shows excel-
lent linearity between results of scanning confocal mi-
croscopy and relative fluorescein concentration. The
peak height of the fluorescence z-scan thus provides a
quantitative index of aqueous fluid fluorescein concen-
tration. To show that the peak height represents fluo-
rescein in the aqueous fluid rather than in the cornea
Figure 4. Aqueous fluid production. (A) Schematic of apparatus showing transcorneal iontophoretic introduction of fluorescein (top)
and measurement of aqueous fluid fluorescein concentration by scanning confocal microscopy (bottom). (B) Linear relationship be-
tween aqueous fluid fluorescein concentration and peak height of the confocal fluorescence scan. (Left) Fluorescein concentration, mea-
sured in aqueous fluid samples withdrawn immediately after confocal microscopy, versus peak height (mean  SE) of confocal z-scans.
(Right) Representative confocal z-scans of eyes measured after iontophoresis for different times. (C) Time course of fluorescein disappear-
ance from the anterior chamber after transcorneal iontophoretic introduction (mean  SE). (Inset) Log plot showing approximately first-
order fluorescein disappearance kinetics (dashed line) after initial equilibration period. (D) Aqueous fluid production, shown as half-
times (t1/2) for fluorescein disappearance, measured in wild-type and AQP null mice. *, P  0.05 (ANOVA).
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or other fixed structures, confocal microscopy was
done just after washout of the aqueous fluid by dual mi-
cropipette perfusion (Thiagarajah and Verkman, 2002)
of the anterior chamber (30 l/min for 3 min) with
fluorescein-free solution. After washout, peak height
was  4% of that before washout.
Fig. 4 C shows the time course of aqueous fluid fluo-
rescein concentration, deduced by z-scanning confocal
microscopy, for measurements on eight eyes from wild-
type mice. To minimize exposure to anesthetics, mea-
surements on individual mice were made just after ion-
tophoresis and at no more than two subsequent times.
There was an initial increase in aqueous fluid fluores-
cein concentration, probably representing diffusion of
any fluorescein remaining in the corneal stroma, fol-
lowed by a slower decline representing bulk fluid out-
flow (which equals fluid inflow at IOPo). From the plot
of log(fluorescence) versus time (Fig. 4 C, inset), the
t1/2 for fluorescein disappearance was 1.3 h The aque-
ous inflow rate computed from t1/2 and aqueous fluid
volume was 3.6  0.2 l/h. Based on the time course
data in Fig. 4 C, confocal microscopy in subsequent
comparative measurements was done just after ionto-
phoresis and at 1.5 and 3 h.
Fig. 4 D summarizes t1/2 for experiments on 8–10 eyes
in each group. Aqueous fluid production was signifi-
cantly slowed (increased t1/2) by deletion of AQP1
alone, or AQP1 and AQP4 together.
Last, the total fluid volume of the aqueous compart-
ment was measured by direct microcapillary withdrawal
of fluid. Care was taken to ensure nearly quantitative
removal of fluid, as verified by fluorescence measure-
ments in eyes in which the aqueous compartment was
stained with fluorescein. Fig. 5 A summarizes aqueous
fluid volumes, which were quite consistent from mouse
to mouse. Aqueous fluid volume did not differ signifi-
cantly in AQP1 or AQP4 null mice from that in wild-
type mice. Because of the low anterior chamber com-
pliance (0.036 l/mmHg), it is not possible to detect
possible decreases in aqueous fluid volume in AQP null
mice (0.07 l for 2 mmHg change in IOP).
The aqueous fluid samples obtained for volume mea-
surements were assayed for [Cl] using a two-color mi-
crofluorimetry method developed previously for [Cl]
measurements in submicroliter quantities of tear fluid.
Fig. 5 B shows similar [Cl] in aqueous fluid from wild-
type and AQP1 or AQP4 null mice.
D I S C U S S I O N
Experiments were done to investigate whether AQP wa-
ter channels are involved in intraocular pressure regu-
lation and aqueous fluid dynamics. As discussed in the
introduction, the involvement of AQPs in aqueous
fluid dynamics has been proposed, without functional
evidence, from their specific localization in cells in-
volved in aqueous fluid handling. Comparative mea-
surements were done in wild-type mice and mice lack-
ing AQP1 and/or AQP4, an approach that has been in-
formative in defining the role of AQP1 and AQP4 in
renal (Ma et al., 1997, 1998), lung (Bai et al., 1999),
gastrointestinal (Ma et al., 2001), and neuromuscular
(Manley et al., 2000) physiology. AQP1 null mice are
grossly phenotypically normal, but manifest distinct ab-
normalities when stressed by water deprivation, high fat
diet, or certain types of pain. AQP4 null mice also ap-
pear normal but are hearing impaired and show re-
duced brain swelling in response to acute injury. Mea-
surements of the static and dynamic properties of the
aqueous fluid in the mouse eye were quite challenging
and required a series of technical developments. Our
results establish the rates of aqueous fluid inflow and
outflow in the mouse eye, as well as the static aqueous
fluid pressure, volume, and compliance. Comparative
measurements in AQP null mice showed significant re-
ductions in IOP and aqueous fluid production, without
differences in aqueous fluid outflow, volume, [Cl], or
anterior chamber compliance.
IOP was measured using sharp micropipettes based on
the original method described by John et al. (1997). As
detailed in the materials and methods section, a num-
ber of modifications in micropipette design, corneal
penetration procedures, and pressure measurements
were made to give reproducible IOP values in our labo-
ratory. The micropipette method gave stable IOP for
30 min and did not cause leak of aqueous fluid. Advan-
tages of the relatively large (50 m) micropipettes
used here include the ability to record rapid changes in
IOP and to introduce fluids into the aqueous compart-
ment. Recently, a servo-null method was reported for
measurement of IOP in mouse eyes, which utilizes a
small, 5-m diameter micropipette filled with a 3 M
KCl solution (Avila et al., 2001). The servo-null method
also permits continuous recording of IOP, but the small
pipette tip precludes the introduction of fluid into the
Figure 5. Aqueous fluid volume and [Cl]. (A) Aqueous fluid
volumes, obtained by microcapillary sampling, measured on wild-
type and AQP null mice. Data from individual eyes (filled circles)
and mean  SE (open circles) shown. (B) [Cl] measured in the
aqueous fluid samples. Differences not significant.
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aqueous compartment. The IOP measured here in CD1
mice (16.0  0.4 mmHg) and C57/bl6 mice (17.1  0.6
mmHg) is in agreement with IOP measured by John et
al. (1997) for different mouse strains (11.1–19.3 mmHg)
(Savinova et al., 2001) and with the servo-null data
(17.8  0.4 mmHg) (Avila et al., 2001).
Aqueous fluid inflow was determined using a fluores-
cein disappearance method as originally developed for
measurements in the human eye. The principle of this
method is that aqueous fluid inflow and outflow are
equal in the steady-state at physiological IOP, and that
fluorescein removal occurs by bulk fluid outflow. Fluo-
rescein was efficiently introduced into the aqueous
fluid by iontophoresis without trauma to the eye. Initial
attempts to introduce fluorescein by corneal puncture
with small micropipettes were inconsistent because of
fluid leak after micropipette removal, even when at-
tempting to seal the leak using glue or opthalmic su-
ture. Fluorescein concentration in the aqueous fluid
was assayed noninvasively by scanning confocal micros-
copy. Control studies showed that the fluorescence
signal provided a linear, quantitative measure of fluo-
rescein concentration in the aqueous fluid. A full fluo-
rescein disappearance curve, constructed from mea-
surements on multiple mice, was used to select two
times on the exponentially decreasing phase of the dis-
appearance curve for comparative studies of wild-type
versus AQP null mice. Because of limitations in re-
peated or long-term anesthesia in mice, it was not possi-
ble to measure a full fluorescein time course in individ-
ual mice for a three-compartment analysis of fluorescein
disappearance. The two-point analysis method used here
assumes that the kinetics of fluorescein exchange be-
tween the aqueous fluid and cellular/interstitial com-
partment is similar in wild-type and AQP null mice.
Analysis of the kinetics of fluorescein disappearance
in wild-type CD1 mice gave an aqueous fluid inflow rate
of 3.6  0.2 l/h, substantially lower than that of 210
l/h in rabbit eye (Becker and Constant, 1956; Ruben
et al., 1985), 60–105 l/h in monkey eye (Bill, 1971;
Sperber and Bill, 1984), 150 l/h in human eye (Jones
and Maurice, 1966), and 21 l/h in rat eye (Mermoud
et al., 1996). Aqueous fluid production was significantly
reduced in mice lacking AQP1 alone or AQP1/AQP4
together. The impairment in AQP null mice probably
results from decreased water permeability in nonpig-
mented cells in the ciliary epithelium where the bulk of
aqueous fluid is likely to flow.
Aqueous fluid outflow was measured from changes in
IOP in response to continuous and pulsed fluid infu-
sions into the anterior chamber. Based on similar mea-
surements in rat eye (Mermoud et al., 1996), aqueous
fluid outflow was estimated directly from empirically
determined rates of continuous infusion, giving con-
stant IOP at a series of predetermined levels. It is as-
sumed in this method that at constant IOP fluid in-
fusion and outflow are equal in the steady-state. A
second method, which provided quantitative informa-
tion about both static compliance and aqueous fluid
outflow, was the measurement of IOP in response to se-
rial infusions of small (0.1 l) fluid volumes. Data from
both methods indicated an approximately linear in-
crease in aqueous fluid outflow with 	(IOP) with a
slope of 0.36 l/h/mmHg. Outflow was not impaired
in AQP1 null mice, which is consistent with bulk fluid
flow that is predicted not to involve water-selective
AQPs. The reason(s) for AQP1 expression in endothe-
lia of the trabecular meshwork and canal of Schlemm
remain unclear, but our results provide evidence that
they are not related to aqueous fluid outflow. AQP1
appears to be present in numerous capillary beds (Niel-
sen et al., 1993; Hasegawa et al., 1994) without appar-
ent physiological significance (Bai et al., 1999; Moore
et al., 2000; Song et al., 2000b).
In summary, quantitative methods have been estab-
lished to measure the static and dynamic properties of
aqueous fluid in mouse eye, and we report the first data
on aqueous fluid production, outflow, compliance and
volume. These methods should facilitate mechanistic
analysis of the roles of various membrane transporters
on IOP regulation using specific inhibitors or trans-
genic mice. AQP1 and/or AQP4 deletion produced co-
ordinate decreases in IOP and aqueous fluid produc-
tion. However, the clinical significance of the modest
reduction in IOP in AQP-deficient mice remains uncer-
tain. Application of IOP-reducing agents, such as car-
bonic anhydrase inhibitors, reduce IOP by only a few
mmHg in normal human eyes. Further studies are indi-
cated to determine the role of AQP deletion in mouse
models of increased IOP and glaucoma, and when
available, to determine effects of acute AQP inhibition
by specific blockers.
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